journal article·2024-03-20

Long-Acting Heterodimeric Paclitaxel–Idebenone Prodrug-Based Nanomedicine Promotes Functional Recovery after Spinal Cord Injury

Zunkai Xu, Xinjie Liu, Yilin Pang, Zhixia Chen, Yaoyao Jiang, Tao Liu, Jiawei Zhang, Haoning Xiong, Xiang Gao, Jiao Liu, Shen Liu, Guangzhi Ning, Shiqing Feng, Xue Yao, Shutao Guo

Nano Letters· Volume 24· Issue 11
Publisher page

Abstract

After spinal cord injury (SCI), successive systemic administration of microtubule-stabilizing agents has been shown to promote axon regeneration. However, this approach is limited by poor drug bioavailability, especially given the rapid restoration of the blood-spinal cord barrier. There is a pressing need for long-acting formulations of microtubule-stabilizing agents in treating SCI. Here, we conjugated the antioxidant idebenone with microtubule-stabilizing paclitaxel to create a heterodimeric paclitaxel-idebenone prodrug via an acid-activatable, self-immolative ketal linker and then fabricated it into chondroitin sulfate proteoglycan-binding nanomedicine, enabling drug retention within the spinal cord for at least 2 weeks and notable enhancement in hindlimb motor function and axon regeneration after a single intraspinal administration. Additional investigations uncovered that idebenone can suppress the activation of microglia and neuronal ferroptosis, thereby amplifying the therapeutic effect of paclitaxel. This prodrug-based nanomedicine simultaneously accomplishes neuroprotection and axon regeneration, offering a promising therapeutic strategy for SCI.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Spinal Cord Injury Research · Nerve injury and regeneration · Synthetic Organic Chemistry Methods

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Functional Polymer Materials of Ministry of Education, State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Center for New Organic Matter, College of Chemistry, Nankai University, Tianjin, 300071, China

Tianjin Key Laboratory of Spine and Spinal Cord, International Science and Technology Cooperation Base of Spinal Cord Injury, Department of Orthopedics, International Chinese Musculoskeletal Research Society Collaborating Center for Spinal Cord Injury, Tianjin Medical University General Hospital, Tianjin 300070, China

Center of Medical and Health Analysis, Peking University Health Science Center, Beijing 100191, China

Orthopedic Research Center of Shandong University and Department of Orthopedics, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan 250012, China

Funding

Natural Science Foundation of Tianjin Municipality · National Natural Science Foundation of China · Nankai University Eye Institute · Beijing-Tianjin-Hebei Basic Research Cooperation Project

References (34)

Show source-provided references
1. 10.1038/nrdp.2017.1810.1038/nrdp.2017.18 ↗
2. 10.1038/s41580-022-00562-y10.1038/s41580-022-00562-y ↗
3. 10.1038/sj.sc.310168110.1038/sj.sc.3101681 ↗
4. 10.1074/jbc.275.8.553510.1074/jbc.275.8.5535 ↗
5. 10.1126/science.120114810.1126/science.1201148 ↗
6. 10.1126/science.aaa295810.1126/science.aaa2958 ↗
7. 10.1002/jnr.1075910.1002/jnr.10759 ↗
8. 10.3389/fonc.2022.94023910.3389/fonc.2022.940239 ↗
9. 10.1016/j.jconrel.2017.06.03010.1016/j.jconrel.2017.06.030 ↗
10. 10.1016/j.jconrel.2016.03.04110.1016/j.jconrel.2016.03.041 ↗
11. 10.1021/acs.molpharmaceut.2c0034810.1021/acs.molpharmaceut.2c00348 ↗
12. 10.1016/j.bioactmat.2021.01.02910.1016/j.bioactmat.2021.01.029 ↗
13. 10.1038/s41467-023-39745-210.1038/s41467-023-39745-2 ↗
14. 10.1039/D2CS00673A10.1039/D2CS00673A ↗
15. 10.1016/j.addr.2023.11486010.1016/j.addr.2023.114860 ↗
16. 10.1038/s41586-019-1707-010.1038/s41586-019-1707-0 ↗
17. 10.1038/s41586-023-06255-610.1038/s41586-023-06255-6 ↗
18. 10.1038/s41586-019-1705-210.1038/s41586-019-1705-2 ↗
19. 10.1016/j.jconrel.2020.02.00910.1016/j.jconrel.2020.02.009 ↗
20. 10.1002/adhm.20160041510.1002/adhm.201600415 ↗
21. 10.1038/ncomms1198010.1038/ncomms11980 ↗
22. 10.1002/smll.20190641510.1002/smll.201906415 ↗
23. 10.1186/s12974-022-02531-w10.1186/s12974-022-02531-w ↗
24. 10.21037/atm-21-206310.21037/atm-21-2063 ↗
25. 10.1016/j.neures.2010.02.00910.1016/j.neures.2010.02.009 ↗
26. 10.1089/neu.1995.12.110.1089/neu.1995.12.1 ↗
27. 10.1016/S0003-9993(98)90213-110.1016/S0003-9993(98)90213-1 ↗
28. 10.1186/s40634-017-0105-510.1186/s40634-017-0105-5 ↗
29. 10.1089/neu.2006.23.165410.1089/neu.2006.23.1654 ↗
30. 10.1016/S0006-8993(00)02778-510.1016/S0006-8993(00)02778-5 ↗
31. 10.1016/j.conb.2018.02.02410.1016/j.conb.2018.02.024 ↗
32. 10.1016/j.expneurol.2011.08.00810.1016/j.expneurol.2011.08.008 ↗
33. 10.1016/j.jconrel.2021.06.02410.1016/j.jconrel.2021.06.024 ↗
34. 10.1021/acsnano.3c0036010.1021/acsnano.3c00360 ↗